Pharmacological Action of Multi-Target-Directed Proberberine on Anti-Alzheimer's Disease

Qing CHEN,Wenshang FENG,Feng HE,Ling ZHONG

DOI: https://doi.org/10.3321/j.issn:0529-6579.2009.05.018

2009-01-01

Abstract:Proberberine is an isoquinoline alkaloid with the same pharmacophore. In this studies we explored the Multi-targeted effect of Berberine and tetrahydropalmatine (THP) which are representative of probererine, and their molecular mechanisms of anti-Alzheimer's disease. SH-SY5Y cells were treated with Berberine or THP, the BACE1 protein level, the secretion of sAPPα and the AChE activity were respectively measured by western blot analysis, ELISA assay and AChE activity detection kit. The results showed that, after drug treatments for 24 hours, both Berberine and THP can significantly inhibit the expression of BACE1, increase the secretion of sAPPα, and decrease the AChE activity, but not change full length APP protein lever. These results demonstrated that the pharmacological effects of Proberberine were involved in prevention and reduction of Aβ level, enhancement of the effect of acetylcholine on acetylcholine receptor in the brain, and increase of the secretion of neurotrophic sAPPα. Our results suggest that Proberberine has multi-target-directed therapeutical potential on Alzheimer's disease, and through structural optimization, it is promising for the development of new anti-AD drugs with less side effects.